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Carbon monoxide (CO) is an endogenously produced gasotransmitter, which is associated
with cytoprotection and cellular homeostasis in several distinct cell types and tissues.
CO mainly targets mitochondria because: (i) mitochondrial heme-proteins are the main
potential candidates for CO to bind, (ii) many CO’s biological actions are dependent
on mitochondrial ROS signaling and (iii) heme is generated in the mitochondrial
compartment. Mitochondria are the key cell energy factory, producing ATP through
oxidative phosphorylation and regulating cell metabolism. These organelles are also
implicated in many cell signaling pathways and the production of reactive oxygen
species (ROS). Finally, mitochondria contain several factors activating programmed cell
death pathways, which are released from the mitochondrial inter-membrane space upon
mitochondrial membrane permeabilization. Therefore, disclosing CO mode of action at
mitochondria opens avenues for deeper understanding CO’s biological properties. Herein,
it is discussed how CO affects the three main aspects of mitochondrial modulation of cell
function: metabolism, redox response and cell death.
Keywords: mitochondria, carbon monoxide, cytochrome c oxidase, reactive oxygen species, mitochondrial
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INTRODUCTION
Carbon monoxide (CO) is mostly known as a silent-killer
due to its great affinity to hemoglobin, which compromises
oxygen delivery and promotes high levels of intoxication and
death. Nevertheless, in 1949 CO was found to be an endoge-
nous molecule, exhaled by healthy humans (Sjostrand, 1949).
Late, Tenhunen and colleagues described heme oxygenase (HO)
enzyme, whose activity is degrading heme group, which gives
rise to CO, along with bilirubin and free iron (Tenhunen
et al., 1968). Nowadays, HO activity is well accepted to present
several beneficial biological functions. There are two known
isoforms of this enzyme, which can be expressed (isoform
HO-1) or activated (isoform HO-2) in response to numer-
ous biological stresses, namely: oxidative stress, hypoxia, hyper-
oxia, hypothermia, unfolded protein response, inflammation,
and ischemia (Ryter, 2006; Gozzelino et al., 2010). Several
reasons are stated for HO to be a homeostatic and cyto-
protective enzyme. First, HO is crucial for eliminating free
heme, which is a potent damaging molecule, due to its free
iron that generates hydroxyl radicals through Fenton reaction
(Gozzelino et al., 2010). Secondly, bilirubin is rapidly con-
verted into biliverdin, which is a potent anti-oxidant molecule
(Dore et al., 1999; Rodella et al., 2006; Ryter, 2006). Finally,
CO is involved in several cellular processes, acting as anti-
inflammatory, cytoprotective, maintenance of tissue homeostasis
and, in some particular cases, anti-proliferative and vasodilator
(Bilban et al., 2008; Motterlini and Otterbein, 2010; Queiroga
et al., 2014).
For potential clinical applications of CO, the main scien-
tific and technical challenges are the safe and specific manner
of delivering CO. Inhalation of CO gas present several limita-
tions: need of hospital environment and devices, risk of high
levels of carboxyhemoglobin and tissue/organ unspecific deliver
of CO. The development of CO-releasing molecules (CORMs)
emerges as a potential solution for CO deliver, as reviewed in
Romao et al. (2012). In experimental approaches (rodent in vivo
or cell culture models), the most studied CORMs are the sodium
boranocarbonate water soluble CORM-A1, the metal-carbonyl
based CORM-2 and its water soluble related molecule CORM-3
(Boczkowski et al., 2006).
Mitochondria are the main cellular energy generators through
oxidative phosphorylation and participate in several signaling
cascades. Mitochondria operate in the adaptive responses to
perturbations in cellular homeostasis, via modulation of cell
metabolism (autophagy response, remodeling of mitochondrial
network), participation on danger signaling (such as mitochon-
drial reactive oxygen species, ROS, or fragments of released
mitochondrial DNA) and regulation of programmed cell death
(Galluzzi et al., 2012). There are three main reasons pointing
mitochondria as the main cellular organelle for CO’s biologi-
cal functions: (i) the main potential candidates for CO to bind
are mitochondrial heme-proteins, (ii) CO’s biological actions are
dependent on mitochondrial ROS signaling and (iii) HO’s sub-
strate heme is generated in mitochondrial compartment. Indeed,
heme biosynthesis consists of eight sequential enzyme-catalyzed
steps. The first and the three last steps of this pathway occur in
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mitochondria. In the last one, ferrous iron is inserted into proto-
porphyrin IX by ferrochelatase in mitochondrial matrix (Ajioka
et al., 2006).
Therefore, the present mini-review addresses how CO mod-
ulates mitochondrial function to promote cell homeostasis and
cytoprotection, and to modulate cell metabolism. The main
focused processes are: (i) mitochondrial biogenesis, (ii) mod-
ulation of enzymatic activity of cytochrome c oxidase, (iii)
generation of mitochondrial ROS for signaling and (iv) induc-
tion of mitochondrial mild uncoupling effect. Furthermore, this
review also targets how CO prevents mitochondrial membrane
permeabilization (MMP) and consequently programmed cell
death.
CO’S BINDING CANDIDATES
Comparing to other gasotransmitters, such as nitric oxide (NO)
and hydrogen sulfide (H2S), CO is a quite inert molecule. CO
needs to be activated by coordination with low-valent met-
als or ions to chemically react. In biological systems, Fe2+ of
reduced heme proteins are the main CO targets (Boczkowski
et al., 2006; Romão and Vieira, 2013). The best-described candi-
dates are hemoglobin (erythrocytes), myoglobin (myocytes) and
cytochrome c oxidase (mitochondrial complex IV).
Cytochrome c oxygenase (COX), the final electron acceptor
of mitochondrial respiratory chain, was found to be the main
mitochondrial target for CO at cytochrome a and a3 (Chance
et al., 1970; Brown and Piantadosi, 1990). COX is involved in CO-
induced cytotoxicity due to CO capacity of inhibiting its activity
and cell respiration (Chance et al., 1970). The binding of CO to
COX is highly dependent on oxygen levels, because under hyper-
baric oxygen conditions there is dissociation of a cytochrome a
and a3-CO complex (Brown and Piantadosi, 1990).
CYTOCHROME C OXIDASE (COX) ACTIVITY AND
MITOCHONDRIAL ROS SIGNALING
Although it is largely accepted that CO is cytotoxic by inhibiting
COX activity and mitochondrial respiration, low amounts of CO
promote cytoprotection via modulation of its enzymatic activity.
Low amounts of CO induce partial and/or reversible inhibition of
COX activity, which accumulates electrons at complex III, gener-
ating low amounts of ROS that are important signalingmolecules,
as reviewed in Bilban et al. (2008), Queiroga et al. (2012). These
produced ROS are in low amounts because they are not causing
damage, cells still consume oxygen and produce ATP following
CO treatment; nevertheless they can be measured by fluorescent
dyes (such as MitoSox and DCF) (Vieira et al., 2008; Queiroga
et al., 2010, 2011). Furthermore, the CO-reduced inflammation
in macrophages is prevented by the addition of N-acetyl-cysteine,
which is a precursor of glutathione synthesis, reinforcing the cell
anti-oxidant defense. Thus, it indicates that mitochondrial ROS
are crucial signaling factors (Zuckerbraun et al., 2007). In mito-
chondrial DNA-deficient cells, ρ0 cells, which are cells deficient
in mitochondrial respiration, the anti-inflammatory role of CO
is lost (Chin et al., 2007). Likewise, in a model of fulminant
hepatitis, overexpression of HO-1 and exogenous CO protect
hepatocytes against apoptosis via mitochondrial ROS genera-
tion, since in ρ0 cells no protection and no ROS generation were
found (Kim et al., 2008). In airway smooth muscle cells, CORM-
2 limits cell proliferation via ROS generation due to a decrease
on COX activity (Taillé et al., 2005). Furthermore, in isolated
liver mitochondria, CO limits MMP and damage, and this effect
is reverted by the anti-oxidant β-carotene addition (Queiroga
et al., 2011). Nevertheless, one can speculate that CO signaling
is not limited to ROS generation, but also involves partial inhi-
bition of mitochondrial respiration. The CO-induced decrease
on mitochondrial respiration and ATP production might create a
compensatory effect, promoting the activation of mitochondrial
biogenesis, which is discussed in the next subsection.
One of the consequences of CO-induced ROS generation is
the mitochondrial increase on the ratio between oxidized (GSSG)
and reduced (GSH) glutathione, facilitating signaling via protein
glutathionylation. In non-synaptic mitochondria derived from
brain cortex, CO limits mitochondrial damage by promoting glu-
tathionylation of the ATP/ADP carrier in their inner membrane,
which improves its function (Queiroga et al., 2010). Furthermore,
the cytosolic protein p62 is another example of glutathionylated
protein in response to CO. In fact, CORM-2 limits inflammatory
responses in endothelial cells via mitochondrial ROS generation
that promotes glutathionylation of p62, which, in turn, pre-
vents NF-κB activation (Yeh et al., 2014). Finally, in activated
macrophages, CO decrease their inflammatory response by par-
tially inhibiting mitochondrial respiration and COX activity, and
its effect is exacerbated under hypoxia (D’Amico et al., 2006).
In apparent contrast, there are also data demonstrating that
CO improves COX enzymatic activity. In a renal model of
diabetes, whose COX activity is lower than control, stimula-
tion of HO-1 expression improves mitochondrial function and
COX activity (Di Noia et al., 2006). Stabilization of hypoxia-
inducing factor-1α (HIF-1α) improves COX function and opti-
mizes mitochondrial respiration efficiency (Fukuda et al., 2007).
Additionally, CO promotes stabilization of HIF-1α in cardiomy-
ocytes (Lakkisto et al., 2010) andmacrophages (Chin et al., 2007).
Taken all together, one can speculate that (i) CO modulates COX
activity via stabilization of HIF-1α and/or (II) CO-induced low
amounts of ROS promote a compensatory and precondition-
ing effect that improves mitochondrial function and promotes
mitochondrial biogenesis.
One must take into consideration that CO’s modulation of
COX activity is also dependent on concentration and on period
of gas exposure. For instance, in vivo exposure of CO gas at
1000 ppm, which are high concentration levels, caused decrease
on myocardial COX activity in mice (Iheagwara et al., 2007).
While, a two-step response was found in CO-treated mitochon-
dria from liver (Queiroga et al., 2011) and from astrocytes
(Almeida et al., 2012). During the first minutes (up to 10)
there was a slight decrease on COX activity, while at later times
(hours) an increase on specific enzymatic activity was found after
CO addition. Thus, a compensatory response of COX activity
and oxidative phosphorylation process might be involved follow-
ing CO’s partial inhibition of COX. Likewise, it was previously
demonstrated that guinea pig model prolonged exposure to CO
resulted in an increase in COX expression in heart and liver, being
these responses considered to be adaptive to chronic exposure
(Shigezane et al., 1989).
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MITOCHONDRIAL BIOGENESIS
Mitochondrial biogenesis seems to be another strategy for the cell
to improve metabolism and confer cytoprotection against sev-
eral damaging stimuli. The axis HO-1/CO positively influences
mitochondrial biogenesis in a ROS-signaling dependent path-
way, as reviewed in Piantadosi and Suliman (2012). HO-1/CO
system reverts the decrease of mitochondrial biogenesis due to
doxorubicin-induced cardiotoxicity in a murine model of car-
diomyopathy (Suliman et al., 2007a). Also, CORM-3 rescues mice
from peritonitis–induced sepsis by supporting cardiac mitochon-
drial metabolism and decreasing pro-inflammatory biomarkers
(TNF-α, NO, and IL-10) in plasma (Lancel et al., 2009). Likewise,
CO gas activates HO-1 expression through NF-E2–related factor-
2 (Nrf2) transcription factor, promoting mitochondrial biogen-
esis and rescuing mice from lethal Staphylococcus aureus sepsis
(MacGarvey et al., 2012). In a human assay, 1 h/day of 250 ppm of
CO gas exposure during 5 days increases mitochondrial biogene-
sis in skeletal muscle cells (Rhodes et al., 2009). Finally, activation
of mitochondrial biogenesis is cytoprotective in response to retic-
ulum endoplasmic stress in macrophages (Zheng et al., 2012) and
against oxidative stress in astrocytes (Almeida et al., 2012).
Modulation of mitochondrial biogenesis by CO is ROS
dependent because: (i) it is controlled by the redox-regulated
Nrf2 transcription factor (Piantadosi et al., 2008) and (ii) the
anti-oxidant catalase reverts CO-induced mitochondrial bio-
genesis (Suliman et al., 2007b). In conclusion, mitochondrial
biogenesis appears as a compensatory process for pushing cell
back to homeostasis, following mitochondrial ROS genera-
tion. One can speculate that CO promotes a precondition-
ing effect and reinforces cellular endogenous cytoprotective
mechanisms.
CO’S PROTECTION AGAINST MITOCHONDRIAL MEMBRANE
PERMEABILIZATION (MMP)
Mitochondrial control of programmed cell death is regulated
by many factors presented in the inter-membrane space of
mitochondria, in particular inside the cristae compartments.
Following cell death activation, factors, such as cytochrome c,
SMAC or apoptosis-inducing factor (AIF) are released into the
cytosol (Kroemer et al., 2007). Thus, MMP is a key event on the
release of these pro-cell death factors. As an anti-apoptotic gaso-
transmitter, CO also modulates MMP. Namely, CO protects PC12
cell (neuronal model) against peroxinitrite-induced cell death,
by preventing mitochondrial membrane potential loss (a conse-
quence of MMP) and the release of cytochrome c (Li et al., 2006).
Hyperoxia-induced lung endothelial cell death occurs via intrin-
sic mitochondrial pathways and CO protects them by inhibiting
cytochrome c release and activation of caspase 3/9 as well as by
preventing Bax translocation into mitochondria and Bid acti-
vation, both events which facilitate MMP (Wang et al., 2007).
By using isolated mitochondria techniques, it was possible to
demonstrate that CO directly targets mitochondria preventing
MMP induced by calcium and atractyloside treatment. In non-
synaptic mitochondria isolated from brain cortex (Queiroga et al.,
2010) and from mitochondria isolated liver (Queiroga et al.,
2011), low amounts of CO gas inhibit several processes related to
MMP: mitochondrial swelling, loss of mitochondrial membrane
potential, permeabilization of inner membrane to molecules
lower then 800Da and the release of cytochrome c. Similarly to
intact cells, in isolated mitochondria, ROS generation is crucial
for CO to regulate MMP, since CO protection is reverted in the
presence of β-carotene (Queiroga et al., 2010, 2011).
MITOCHONDRIAL UNCOUPLING AND CO
Mitochondrial oxidative metabolism is accompanied by ROS gen-
eration due to the incomplete reduction of oxygen into anion
superoxide. Under proper control, ROS generation functions as
ubiquitous signaling factors. However, under pathological con-
ditions, reversion of electron flow might result in persistent and
damaging generation of ROS, thus mild mitochondrial uncou-
pling is an inherent cellular mechanism to limit oxidative stress.
Uncoupling consists of energy dissipation by the leakage of proton
through the inner membrane, causing a compensatory increase
on oxygen consumption, which is not coupled with ATP pro-
duction. Iacono and colleagues have demonstrated that CORM-3
protects mitochondria against oxidative stress by inducing mild
uncoupling state (Iacono et al., 2011). Low micromolar concen-
trations of CORM-3 increase oxygen consumption under state 2
of respiration (in an ADP independent manner), indicating an
uncoupling effect between oxygen reduction and ATP produc-
tion.Moreover, an inhibitor of succinate dehydrogenase (complex
II), malonate significantly reverses the CORM-3-induced uncou-
pling effect. Likewise, inhibitors of uncoupling protein (UCP)
and ATP/ADP translocator (ANT), which are proteins involved in
mitochondrial uncoupling process, also prevented mitochondrial
uncoupling due to low concentrations of CORM-3. Whenever
respiration is initiated at complex II by using succinate as sub-
strate, there is a reversion of electron transfer to complex I
with higher levels of ROS production. Under these conditions,
CORM-3 prevented excessive ROS generation, limiting oxidative
stress (Iacono et al., 2011). In contrast, when electron trans-
fer is physiologically initiated by addition of pyruvate/malate,
CORM-3 promotes ROS generation at complex III due to com-
plex IV inhibition, under a concentration-dependent manner.
Since Iacono and colleagues generated these data using an in vitro
approach (isolated mitochondria), one can speculate whether this
CO-promoted mild uncoupling effect is physiologically relevant
under pathological conditions.
In a recent and more detailed approach, same authors have
found that CO targets phosphate carrier. In fact, by increasing
phosphate carrier activity, CO promotes the transport of protons
and phosphate inside mitochondria, inducing a mild uncoupling
effect (Long et al., 2014).
ION CHANNELS AND CO
Phosphate carrier is not the single channel involved in CO’s
biological activity. CO also modulates other ion channels. The
molecular mechanisms by which this regulation takes place are
still uncertain and the direct binding of CO to ion channels is
controversial since there is no transition metal present in the
structure of these molecules (Peers et al., 2014). Nevertheless,
calcium-activated potassium (KCa) channels can bind covalently
to heme (Tang et al., 2003), thus one can speculate that CO could
indirectly bond through heme group.
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CO (CORM-2 and/or dissolved gas) inhibited cardiomyocyte
L-type Ca2+ currents. This effect was reverted in the presence of
mitochondrial complex III inhibitor (antimycin A) or mitochon-
drial target anti-oxidant (Mito Q), which limits mitochondrial
ROS generation (Scragg et al., 2008). Likewise, CO inhibited
L-type Ca2 channel in a ROS dependent manner, conferring
cardioprotection (Dallas et al., 2009). In addition, the loss of
intracellular levels of K+ is one of the early steps of apopto-
sis modulation, since intracellular K+ maintains mitochondrial
potential and volume and cell osmolality. K+ efflux occurs via
potassium channels, and Kv2.1 channel is particularly involved.
In hippocampus CO prevented neuronal apoptosis by selectively
inhibiting Kv2.1 channel. Similarly to Ca2 channels, CO inhibits
Kv2.1 channel in a ROS dependent manner, since this effect is
reverted in the presence of specific mitochondrial anti-oxidant
Mito Q (Dallas et al., 2011).
Finally, calcium transportation into mitochondria is another
important and potential CO role, which needs further studies.
FINAL REMARKS
At first glance, CO mode of action on mitochondria appears
to be deleterious, such as: inhibition of COX, ROS generation
or uncoupling effect. Nevertheless, the final results are benefi-
cial for the cell, whereas low amounts of ROS generation (i)
modulates plasmatic ion channel activity, (ii) improves mito-
chondrial metabolism, (iii) promotes mitochondrial biogenesis
and (iv) prevents MMP and cell death. Likewise, at low concen-
trations of CO, there is an improvement of COX activity and
an induced mild uncoupling that protects mitochondria from
oxidative stress. Thus, one can speculate that CO promotes a
preconditioning effect at the cellular level. Figure 1 summarizes
the main findings concerning CO mode of action.
Nevertheless, several aspects of CO’s modulation of mito-
chondrial function are still unrevealed and faraway from being
understood. Namely, COmight affect mitochondrial quality con-
trol machinery, probably through ROS signaling. Mitochondrial
quality control consists of several processes that must be in
balance: (i) mitochondrial adaptation to the cell environment
by fusion and fission processes, (ii) elimination of damaged
mitochondria by mitochondrial autophagy (mitophagy) and
(iii) mitochondrial biogenesis. Further studies are necessary
to describe how CO modulates these events and their cross
talk.
In addition, mitochondria and endoplasmic reticulum (ER)
are physically and functionally related (Naon and Scorrano,
2014). Indeed, ER stress promotes adaptive mitochondrial
response (increase on ATP production and mitochondrial bio-
genesis) through mechanisms that are HO-1/CO dependent
(Zheng et al., 2012). However, this inter-organelle communica-
tion is still an unexplored field for CO research.
Furthermore, it seems that CO can modulate protein function
through redox modulation of critical cysteine residues, following
mitochondrial ROS generation. Protein post-translational mod-
ifications are key processes for rapid cellular redox response, in
particular protein glutathionylation due to the high levels of oxi-
dized glutathione. Thus, it is an aspect of CO’s Biology that needs
further studies.
Finally, mitochondria emerge as crucial target organelles for
the system HO-1/CO, through which cellular homeostasis and
survival are modulated.
FIGURE 1 | The main described mechanisms of carbon monoxide on
mitochondria: modulation of mitochondrial membrane permeabilization
and cell death control; improvement of mitochondrial metabolism
(modulation of cytochrome c oxidase activity and mitochondrial
biogenesis), ROS generation and signaling (redox adaptive cell
responses, alert signals) and mild uncoupling effect.
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